POLYMYALGIA RHEUMATICA (PMR)
Clinical trials for POLYMYALGIA RHEUMATICA (PMR) explained in plain language.
Never miss a new study
Get alerted when new POLYMYALGIA RHEUMATICA (PMR) trials appear
Sign up with your email to follow new studies for POLYMYALGIA RHEUMATICA (PMR), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill could help seniors ditch steroids for painful muscle disease
Disease control Recruiting nowThis study tests whether adding baricitinib (a JAK inhibitor pill) to standard steroid treatment helps people with polymyalgia rheumatica (PMR) achieve disease control without needing long-term steroids. About 140 adults aged 50+ with active PMR will receive baricitinib (2 mg or …
Matched conditions: POLYMYALGIA RHEUMATICA (PMR)
Phase: PHASE3 • Sponsor: University Hospital, Brest • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
Blood test could end guesswork in treating arthritis and autoimmune diseases
Diagnosis Recruiting nowThis study aims to develop a blood test that can predict which medication will work best for each person with a rheumatic disease like rheumatoid arthritis or lupus. Researchers will take a blood sample and test how immune cells react to different drugs in the lab. The goal is to…
Matched conditions: POLYMYALGIA RHEUMATICA (PMR)
Sponsor: University of Bonn • Aim: Diagnosis
Last updated Jun 16, 2026 22:47 UTC
-
New scan could spare elderly from unnecessary steroid side effects
Diagnosis Recruiting nowThis study aims to improve how doctors diagnose polymyalgia rheumatica (PMR), a painful inflammatory condition common in older adults. Current methods often lead to misdiagnosis and unnecessary treatment with steroids, which have serious side effects. Researchers will use a new P…
Matched conditions: POLYMYALGIA RHEUMATICA (PMR)
Sponsor: Kresten Krarup Keller • Aim: Diagnosis
Last updated Jun 09, 2026 12:10 UTC
-
Blood protein may spare PMR patients from unnecessary artery tests
Diagnosis Recruiting nowThis pilot study is looking for a blood marker (thrombomodulin) that can tell whether a person with polymyalgia rheumatica (PMR) also has giant cell arteritis (GCA), a more serious condition that can cause blindness or stroke. Researchers will measure thrombomodulin levels in 78 …
Matched conditions: POLYMYALGIA RHEUMATICA (PMR)
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Diagnosis
Last updated Jun 03, 2026 12:03 UTC
-
Steroid withdrawal relief: new study tests hydrocortisone for lingering fatigue
Symptom relief Recruiting nowThis study tests whether a low dose of hydrocortisone can relieve symptoms like fatigue and dizziness in people who have stopped taking steroids for giant cell arteritis or polymyalgia rheumatica. About 100 adults aged 50 and older will receive either hydrocortisone or a placebo …
Matched conditions: POLYMYALGIA RHEUMATICA (PMR)
Phase: PHASE4 • Sponsor: Marianne Andersen • Aim: Symptom relief
Last updated Jun 16, 2026 12:52 UTC